WEBINAR: COVID-19 AND IMPACT ON THE US FINANCIAL SYSTEM - Oliver Wyman
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
WEBINAR: COVID-19 AND IMPACT ON THE US FINANCIAL SYSTEM Government response, impact on oil & gas July 29th, 2020 Please note that this session was held at a particular point in time (Wednesday, July 29th, 2020, 4pm-5pm EDT), and in light of the rapidly evolving COVID-19 situation, it is possible these discussions are no longer accurate after that date.
CONFIDENTIALITY Our clients’ industries are extremely competitive, and the maintenance of confidentiality with respect to our clients’ plans and data is critical. Oliver Wyman rigorously applies internal confidentiality practices to protect the confidentiality of all client information. Similarly, our industry is very competitive. We view our approaches and insights as proprietary and therefore look to our clients to protect our interests in our proposals, presentations, methodologies, and analytical techniques. Under no circumstances should this material be shared with any third party without the prior written consent of Oliver Wyman. © Oliver Wyman
WEBINAR AGENDA 1 Epidemiological update 2 The Stimulus Debate 3 The surprising impact of COVID-19 on Oil & Gas 4 Q&A © Oliver Wyman 3
OUR PANELISTS Til Schuermann Douglas Elliott Partner & Co-Head, Risk Partner, Risk & Public & Public Policy Policy Helen Leis Bob Orr Partner, Health & Life Partner & Head of Sciences Americas Energy Practice © Oliver Wyman 4
THE U.S. EXPERIENCE IS A TALE OF TWO SETS OF STRATEGIES AND OUTCOMES Active cases per million for select states The US is divided between the Northeast and As of July 27th, 2020 everywhere else 8,000 Forecast launch • Northeastern states like Massachusetts, New Florida 7,000 York, and New Jersey drove much of the growth in the US in the early pandemic, but 6,000 Georgia have since managed to suppress cases • Now, states in the South and West like 5,000 Florida, Texas, and California that were relatively spared early in the pandemic are 4,000 Texas seeing substantial case growth with some Arizona indication of slowing down in recent days California 3,000 Illinois • Despite a brief respite in the late spring, case Iowa growth is now accelerating across the 2,000 Midwest in states like Iowa or Illinois, Massachusetts threatening to become outbreaks of similar 1,000 New Jersey scale to Southern states New York 0 2/1 2/15 2/29 3/14 3/28 4/11 4/25 5/9 5/23 6/6 6/20 7/4 7/18 8/1 8/15 © Oliver Wyman 6
HOTSPOTS ARE STILL DEALING WITH SUBSTANTIAL DAILY NEW CASES, BUT THERE ARE EARLY INDICATIONS GROWTH MAY HAVE STABILIZED Legend: % Change in new daily cases (2 weeks) Circle size: # of active cases 0% or less 1–25% Testing rates 26–50% 51–100% >10% indicate capacity issue, 101+% suggesting Testing capacity insufficient confirmed case to capture true case growth growth is limited by Fully reopened1 tests, not true caseload in Partially reopened FL2 region Partially reclosed (after reopening) South/West Rural States Midwest Northeast/Mid-Atlantic High Risk Moderate-High Risk Moderate–High Risk Moderate Risk • 9 of 10 states with highest active cases are in • All fully reopened and fared well for multiple • Cases rising across most of the region after • Generally hit hard by initial outbreak South (CA is 3rd) weeks a number of weeks of flat to declining • Cautiously reopening after case decline, • Case growth appears to be slowing, but • Though some case counts are still low, growth though many (NY, NJ, DE) have paused likely a result of limited testing - Several hotspots like Idaho now in top 10 active • Many states (OH, NE, KY, MO, WI, IN, IA, KS reopening plans states (FL, TX, GA, AZ, LA, AL) have positive cases/capita ) have concerning rise in positive test rates • Several states (MD, CT, VA) have 2 week test rates of 15-25% • States with low case counts have seen ~50- >5% case growth >50%, increasing risk • Health system capacity is strained, resulting 75% 2 week case growth (NE, ND, AK, WY), in regulatory changes in many states increasing risk 1. “Fully reopened” defined as when a majority of high risk businesses, including bars, movie theaters, or gyms, have been reopened with indoor service. This chart does not account for regulatory restrictions that may or may not be in place in © Oliver Wyman those businesses, including mask wearing or capacity constraints. 2: Florida has considered reclosure of a number of risky venues, including bars, gyms, & restaurants, but ultimately decided to only reclose bars; thus, Florida is still considered 7 “fully reopened”
DOES SLOWING CASE GROWTH SIGNAL THE END OF THIS WAVE? It is too early to definitively say, but potential explanations are primarily centered on behavioral change Risky business closures – Reclosures of bars, gyms, and other risky businesses in hotspots like AZ, CA, LA, and TX are 1 likely limiting risky behavior and helping to limit transmission Mask mandates – Mask usage in public is now mandated in over 50% of U.S. states, including key hotspots (e.g., AL, CA, 2 LA, TX) – mask wearing demonstrably lowers transmission in states with mandates Increased public compliance – 75% of Americans are now more likely to wear a mask and engage in social distancing 3 than they were in June, reducing risk1 Testing capacity limits – Alternatively, the answer may simply be driven by data integrity, as significant strain on testing 4 capacity constrains our ability to diagnose true scope of outbreak; 14 states (MS, AZ, FL, AL, ID, KS, SC, NV, GA, MO, TX, AR, UT, LA) all have >10% positive testing rates © Oliver Wyman 1. Harris Poll 8
Information as of 7/28/20 HERD IMMUNITY IS A THEORETICAL PROMISE, BUT IF IMMUNITY IS CONFERRED, THE THRESHOLD REQUIRED MAY BE LOWER THAN PREVIOUSLY THOUGHT If herd immunity proves feasible, each region will be on a different path; while potential immunity is far off for most, heavily affected epicenters like NYC may begin to see a dampening effect on transmission Infected proportion of population Emerging perspective 90% US MSAs • We do not currently know if protective immunity is conferred or for 80% what length of time; If protective immunity does not last long (e.g., 6 70% months), we will not achieve herd immunity • Assuming immunity is conferred, progress towards herd immunity 60% varies by region 50% – Key factors include how hard hit a region was and how effective 40% suppression measures are/were 30% • Additionally, it is likely that herd immunity thresholds differ from region to region or from population to population 20% – Heterogeneity of contagiousness (i.e., some patients may be 10% “super-spreaders”, some may be naturally immune) and of 0% interaction (groups are differentiated in how they interact within UK Japan France US Spain Miami Germany Brazil DFW LA NYC and outside of the group) suggest variability in herd immunity thresholds Confirmed Estimated total – low3 Estimated total – high3 • This heterogenous transmission means herd immunity may be more achievable than we first thought, as long as immunity lasts long JP DE FR US ES UK BR DFW LA MIA NYC enough Deaths per 1M5 8 110 460 450 610 680 410 150 370 450 3K Total Deaths5 1K 9K 30K 148k 28K 46K 88K 1K 5K 3K 23K Sources: Total confirmed cases by country as reported by Johns Hopkins University as of 7/7/2020; total confirmed cases by US county as reported by US facts as of 7/7/2020; world population as reported by link; total population for MSAs as © Oliver Wyman reported by Claritas. 1. Estimates for herd immunity for COVID based on R0 of 2–5.7 and a target of R0
REOPENING SCHOOLS IS A CRITICAL AND HOTLY DEBATED ISSUE – IT LIKELY CAN BE DONE SAFELY WHEN COMMUNITY SPREAD IS LOW • America’s economic system can not function fully without schools, placing economic pressure on reopening • Pediatric welfare also depends on in-person learning; students are falling behind and are at greater risk of abuse, neglect, or food insecurity How do we ensure schools are able to reopen safely? • Manage community transmission below risky levels – Keeping community spread low will reduce the likelihood of transmission events within schools, protecting students and teachers • Levy mask mandates in and out of schools – mask mandates demonstrably lower transmission within communities, lowering risk of children contracting or spreading the disease • Shut down or materially alter operations of highest risk businesses – businesses like bars, gyms, or live music venues are some of the riskiest venues to keep open, and shutting them down will have less impact on the economy than keeping schools closed • Increase testing, particularly in the private sector – Existing US testing capacity is not sufficient to capture and mitigate full extent of risk from COVID; By increasing testing both within schools and among private businesses, unexpected spread and outbreaks can be identified quickly and contained • Prioritize return of less risky age groups – multiple studies have suggested children younger than 10 are less at risk of spreading the disease than any other age group, while transmission from those aged 10-19 may be more common than in adults1; adopting hybrid schedules that prioritize younger students may reduce risk and substantially reduce the burden of childcare of younger parents 1. CDC © Oliver Wyman 10
FINDING THE OPTIMAL R(t) BALANCE – REGIONS SHOULD STRIVE TO KEEP AS MUCH OF THE ECONOMY OPEN AS POSSIBLE WITHOUT RISK OF SERIOUS OUTBREAK Case growth – long haul suppression Rapid Case Growth Limited suppression measures until public health strain is too high, followed by broad, reactive suppression measures in response Rapid progress towards herd immunity during “open” periods1 Economic instability driven by need to reclose broadly when case counts rise too high Risk Threshold Population less willing to “reclose”, leading to lower compliance and less effective suppression Managing Rt Proactively tighten & ease suppression to maintain balance & keep Rt just below risk Case Growth per Day threshold; proper testing important to accurately calculate Rt Economy is as open as possible without threatening health infrastructure Maximal herd immunity without overwhelming health system Limited need for reactive, destabilizing suppression measures Cautious suppression Targeted suppression measures levied well before growth approaches risk threshold Limited public health risk Lower case count enables targeted suppression Next 12+ Longer road to herd immunity Months Higher likelihood of extended unemployment/economic disruption © Oliver Wyman 1. Assumes protective immunity is conferred and lasts long enough for herd immunity to be impactful 11
Information as of 7/28/20 MASK MANDATES ARE HIGHLY CORRELATED TO CURRENTLY FLAT OR DECLINING CASE GROWTH Washington Montana North Dakota • Mask mandates are highly correlated with declining case growth Minnesota New Hampshire – Evidence suggests that up to 450k cases may have been avoided Wisconsin Vermont due to mask mandates as of May 221 Oregon South Dakota Maine Wyoming Massachusetts – Daily case rates declined by up to two percentage points after Iowa Michigan West signing a mask mandate, with the effect increasing over time1 Idaho Virginia New York Nebraska Nevada Utah Illinois Pennsylvania California Ohio Colorado Missouri Rhode Island Kansas Connecticut Indiana New Jersey • Though mandates are most common in the hard-hit Northeast, Kentucky Virginia Maryland evidence suggests efficacy in other regions Arizona New Mexico Oklahoma Washington, D.C. Arkansas Texas Tennessee North Carolina – Despite proximity to the current outbreak centers in the south and west, both Kentucky and New Mexico have mostly avoided Missi ssippi Alabama Georgia South Carolina serious case growth Louisiana Florida Alaska • Many states have employee only mask mandates in effect; effects of these on case rates are insignificant1 Hawaii • Efficacy of newly instituted mandates remains to be seen – New epicenters (CA, TX, NC, etc.) have recently instituted mandates, but efficacy partially relies on public compliance LEGEND: Masks recommended in public Masks required in public post June 1st Masks required in public pre June 1st 1.Health Affairs © Oliver Wyman 12
KEEPING COMMUNITY SPREAD LOW LIKELY REQUIRES HIGH RISK BUSINESSES TO STAY CLOSED OR SIGNIFICANTLY CHANGE OPERATIONS Risk of reopening Less risky More risky Most risky Can easily accommodate and enforce distancing, PPE, Can reasonably implement safety protocols, but contact Can not reasonably enforce safety protocols; indoors with hygiene protocols, and capacity limits; preferably outdoors above recommended levels is likely; indoor activities that limited circulation; mass gatherings or events not facilitate transmission conducive to distancing; spaces conducive to • Car dealerships • In-store retail yelling/singing • Takeout • Movie theaters • Dine-in restaurants • Medical appointments • Office space (i.e., corporate buildings) • Bars • Outdoor recreation (e.g., golf, fishing, tennis) • Public transit • Concerts or sporting events • Appointment-based personal services (e.g., nail salon, • Religious services barbershop) • Gyms/fitness studios Reopening risky businesses should take place under specific circumstances and with abundant safety measures Reopening should likely wait until cases are extremely The “new normal” requires new standards and operating Authorities should be prepared to reclose if necessary low procedures • It is likely too early to fully determine the impact of • New daily cases were
FEW STATES HAVE ADEQUATE TESTING CAPACITY TO ADDRESS EXISTING CASE GROWTH New cases per thousand (including undetected cases) by tests per thousand for each state As of July 27th, 20201 0.55 Below average testing, above average cases Above average testing, above average cases 0.50 Florida New cases per thousand (7-day rolling average) Mississippi 0.45 Louisiana 0.40 Alabama 0.35 Arizona Tennessee Nevada Georgia South Carolina 0.30 Texas These states may lack Idaho 0.25 the infrastructure to Oklahoma detect a resurgence Missouri Arkansas California Strongest existing 0.20 of cases rapidly Wisconsin North Dakota North Carolina capacity Kansas Iowa Utah Indiana New Mexico 0.15 Kentucky Alaska Minnesota Below average testing, Colorado Maryland Above average testing, below average cases 0.10 below average cases Wyoming Washington Illinois District of Columbia Michigan 0.05 Hawaii Massachusetts New York New Hampshire Vermont New Jersey Maine 0.00 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8 3.0 3.2 3.4 3.6 3.8 4.0 4.2 4.4 4.6 4.8 6.4 New tests per thousand (7-day rolling average) 1. Quadrants determined using the average of state-level new tests per thousand (7-day rolling average) and average of state-level new cases per thousand (7-day rolling average) © Oliver Wyman 14
SUPPLEMENTAL PRIVATE SECTOR TESTING IS OPERATIONALLY CHALLENGING AND EXPENSIVE, BUT IS IMPORTANT IN RETURN-TO-WORK SCENARIOS Some private institutions are currently or planning …Though operational and cost considerations to regularly and broadly test their workforce… have limited wider adoption • Private sector testing will be highly industry specific, with • Cost and frequency of testing are biggest prohibitors vulnerable employers like airlines implementing earlier – Testing should occur multiple times a week, preferably daily, to – Testing at locations with high likelihood of spreading events or ensure cautious behaviour vulnerable populations (schools, prisons, long-term care facilities) – At $100-150 per test, cost quickly becomes substantial for any • Universities are among the most common organizations planning company with multiple employees tested multiple times a week to ramp up private testing – Certain groups, like the Broad Institute in Boston, have limited – Many universities are ramping up in-house capabilities or costs to
FULL RECOVERY DEPENDS ON A SUCCESSFUL VACCINE, BUT TIMELINE IS UNCERTAIN A successful vaccine manufactured and deployed at scale is the only certain path to eradication How long could that take? • The optimistic timeline suggests a vaccine could be commercially available in mid to late 2021 • The best comparison we have is the development of H1N1 vaccines under similar circumstances, though we are already past the 6mo it took for a vaccine to be approved in that scenario H1N11 6 months until vaccine approval; 12 months critical conditions; 18 months until end of pandemic Mar 2009 Apr 2009 Summer 2009 July 2009 Sep 2009 Dec 2009 Aug 2010 First world-wide US Gov declares Source region Vaccine clinical FDA approves four Vaccine available WHO declares end case emerges state of emergency possibly under control trials begin H1N1 vaccines broadly of pandemic What is the current status of leading candidates? Vaccine program Initial results Current stage Manufacturing scale / timeline Oxford - AstraZeneca • Results from Phase I/II trial showed • Undergoing Phase II/III trial with 10,00 • Manufacturing partners lined up to produce production of a strong immune response with participants in UK, Brazil, South Africa 2B doses (via AstraZeneca and Serum Institute co-occurrence of manageable, mild / • Considering adding Human Challenge Trials of India) and distributed in partnership with moderate side effects GAVI and CEPI Moderna • Results from Phase I trial demonstrated all • Granted FDA fast track (5/12) • Partnership with Catalent (100M initial doses) participants produced antibodies, but had • Currently undergoing Phase IIa (dosage) and b and Lonza to produce 1B doses annually significant side-effects in a dose-dependent (efficacy) trials manner • Beginning Phase III trials on July 27, targeting 30,000 participants Pfizer-BioNtech • Results from Phase I/II trial showed that a 2 • Granted FDA fast track (7/13) for 2 out of 4 • Targeting 100M doses by end of 2020, >1.2B dose vaccination elicited strong antibody investigational vaccines doses by end of 2021 response, but had frequent mild-moderate • Preparing for Phase IIb/III trial targeting adverse effects 30,000 participants late July / August © Oliver Wyman Sources: H1N1 timeline (link), Credit Suisse Equity Research, Nature (link), Artis Ventures (link), Biocentury (link) and DowJones 16
02 THE STIMULUS DEBATE Douglas Elliott Partner, Risk & Public Policy
OVERVIEW OF THE STIMULUS DEBATE ECONOMIC BACKGROUND POLITICAL BACKGROUND KEY QUESTIONS A FEW PREDICTIONS © Oliver Wyman 18
ECONOMIC BACKGROUND • Economic output has taken a huge hit, falling 10-15%, depending on how you measure it, between February and May • The CBO projects economic output over the next 12 months will be $1.3 T lower than if the economy were operating at full potential • The course of the pandemic and the health policy measures used to contain it will strongly influence the extent of the damage • The next largest influence will be the degree of fiscal stimulus • Household incomes in May were actually 5% higher than in February due to massive government aid • But much of the existing stimulus is rolling off this summer, with additional unemployment benefits ending this week, unless there is new legislation © Oliver Wyman 19
POLITICAL BACKGROUND • Politics, especially in this election year, makes it virtually certain additional stimulus will be passed soon • Democrats are united around the idea of a further massive stimulus (with the House passing a $3 Trillion package) • The Administration wants to boost the economy heading into the elections, but not at the expense level the Democrats support • There are some Republican deficit hawks in Congress who are pushing back against a large stimulus program • However, many Congressional Republicans want a sizeable stimulus, meaning there will be an overall majority to pass legislation © Oliver Wyman 20
KEY QUESTIONS What is the SIZE OF THE PROGRAM How much is in the form of GRANTS VS. LENDING Which SECTORS OF THE ECONOMY will receive aid © Oliver Wyman 21
A FEW PREDICTIONS There will be substantial money Businesses will benefit from an extension / expansion of for households through direct the Paycheck Protection grants, payroll tax cuts or other Program means There will be money for The total size will testing and tracing, be in the range of despite earlier opposition $1 Trillion © Oliver Wyman 22
A FEW PREDICTIONS • Congress will try to get more bang for the buck on its previous authorization for Treasury to use funds to back Fed lending programs - Pushing the Fed / Treasury to make the Main Street Lending Program work better - Pushing Treasury to allocate more funds to back Fed programs, including new ones - Commercial real estate lending could be part of this - Congress may throw in some more money to back lending programs, beyond the PPP • States and municipalities will get some funding, especially now that Red states are being hit as hard as some Blue ones were © Oliver Wyman 23
03 THE SURPRISING IMPACT OF COVID ON OIL & GAS Bob Orr Partner & Head of Americas Energy Practice
THE INITIAL COVID-19 OUTBREAK HAS RESULTED IN ~27% DECLINE IN OIL DEMAND, DRIVING OIL PRICES DOWN 2020 Global oil products demand (million barrels/day) Demand shock is unprecedented and affected -27% primarily road and jet fuels Decline of Despite May/June demand oil demand pick-up, pace of demand recovery is still uncertain and uneven across global markets, with 2nd COVID outbreaks a concrete threat New environment is placing significant pressure on regions Jan Feb Mar Apr May Jun with higher cash production costs © Oliver Wyman 25
AS A RESULT, OIL & GAS CO’S ARE SIGNIFICANTLY IMPACTED AND HAVE ENACTED SURVIVAL AND REPOSITIONING MEASURES CAPEX CUTS DIVIDENDS/SHARE BUY BACK LAYOFFS -20% -28% -30% ~2/3 Suspension of share buyback -10-15% -15% dividend cuts © Oliver Wyman 26
SO, WHAT SHOULD OIL AND GAS COMPANIES EXPECT IN THE NEXT 18-24 M? PRICE Crude Prices have progressively recovered to DEMAND $40s/bbl and likely to remain Pace of demand recovery at $30-$50/bbl is still uncertain with demand impact likely extending beyond 2021 SUPPLY New environment is changing oil geopolitical balance and positioning again US shale as the natural swing producer © Oliver Wyman 27
1. Americas Demand AMERICAS: OIL MARKETS WILL RECOVER SLOWER THAN INITIALLY EXPECTED, WITH A DEGREE OF SUSTAINED DEMAND DESTRUCTION Total Products Demand 1 [MMbbl/d] 33 32 OW Fast recovery 2020E: 27.4 MMbbl/d 31 2021E: 30.6 MMbbl/d 30 30 -2% at end of 2021 compared to 29 Pre-COVID Baseline2 28 27 OW Gradual recovery 26 2020E: 27.1 MMbbl/d 26 2021E: 29.7 MMbbl/d 25 -4% at end of 2021 compared to 24 24 Pre-COVID Baseline2 23 22 22 EIA Pre-COVID Baseline2 OW Slow recovery 21 2020E: 26.5 MMbbl/d OW Fast Recovery 2021E: 29.1 MMbbl/d 20 OW Gradual Recovery -7% at end of 2021 compared to OW Slow Recovery Pre-COVID Baseline2 1 Historical Oil Demand 0 Mar- May- Jul- Sep- Nov- Jan- Mar- May- Jul- Sep- Nov- 20 20 20 20 20 21 21 21 21 21 21 1) Based on scenario outputs of the Oil Navigator 2) Pre-COVID Baseline based on EIA forecast from January 2020 // Source: Oliver Wyman Analysis © Oliver Wyman 28
2. Crude price WE EXPECT OIL PRICES TO BE IN THE $30–50 RANGE OVER THE NEXT 12–24 MONTHS DRIVING DRILLING ACTIVITY DRIVING DOWN Oil (WTI) – historical and forecasts Total US rig count – oil vs natural gas $/barrel, Q3 2019–2021 (forecast) # of rigs 60 58 1,600 2008 price recovery (20–50)% 40 2014 price recovery below 1,400 Q4 ‘19 20 1,200 Forecast 0 Q3 ’19 Q4 ’19 Q1 ’20 Q2 ’20 Q3 ’20 Q4 ’20 Q1 ’21 Q2 ’21 Q3 ’21 1,000 Oil Natural gas (Henry hub) prices – historical and forecasts 800 $/million Btu, Nov 2019–2021 (forecast) 600 -61% 4 400 2 Gas 200 Forecas 0 t 0 Q3 ’19 Q4 ’19 Q1 ’20 Q2 ’20 Q3 ’20 Q4 ’20 Q1 ’21 Q2 ’21 Q3 ’21 2013 2014 2015 2016 2017 2018 2019 Q1’20 Q1’21Q4’21 Source: EIA, Reuters, Company public reports, JP Morgan, Goldman Sachs, Bank of America, Citi, Credit Suisse, Morgan Stanley, Pira, S&P Global Platts, Shell Q1 ’20 earnings, Baker Hughes, Oliver Wyman analysis © Oliver Wyman 29
BESIDES THE SUSTAINED CHALLENGES, THIS CRISIS PRESENTS UNIQUE OPPORTUNITIES FOR OIL COMPANIES Certainly this situation has caused a lot of distress in our industry, but it Another round is in need of consolidation. There's too much fixed cost. Investors have of market too many choices. Your market cap's not relevant anymore. consolidation? Ryan Lance – ConocoPhillips Chairman and CEO, April 30 Increased push Today, we’re a hydrocarbon company. But we will become a different towards type of energy company over time with decarbonization. decarbonization? Bernard Looney – BP CEO, May 13 I fundamentally believe we have a core role to play in the energy Time for energy transition: the capabilities that we have, the scale that we bring, the transition? insights, and everything else. Ben van Beurden – Shell CEO, June 09 © Oliver Wyman 30
THE IMPERATIVE TO ADVANCE DECARBONIZATION STEMS FROM GROWING CARBON RISKS AND LOW-CARBON OPPORTUNITIES Reasons to decarbonize Increasing incorporation of climate and transition risk into credit ratings, Growing impacting cost of capital1 risks for carbon- Investor and shareholder advocacy and divestment. Risk of stranded assets intensive IOCs Expanding carbon regulations, especially carbon pricing schemes and efficiency standards Improved margins available to some renewables and low-carbon tech., Growing in part due to policy incentives, in part due to lower traditional investment returns opportuniti es in low- Potential boost to share price and market valuation carbon sector Growth in renewables and low-emissions tech. driven by customer demand and societal reputation © 1. A study Oliver by CDP found that companies not prioritizing decarbonization receive higher coupon rates, especially on medium- and long-term bonds Wyman 31
OIL CO’S ARE IN EARLY STAGES OF DECARBONIZATION. SOME HAVE SET AMBITIOUS TARGETS BUT HAVE LIMITED PLANS ON HOW TO GET THERE Oliver Wyman Decarbonization Maturity Framework In line with current Paris pledges In line with 2 degrees and below Stages of decarbonization Small steps Shifting gears Low-carbon champion Carbon Neutrality • Small operational/ • Modification of operations • New technologies and • Near zero emissions from process improvements to cut carbon processes to cut carbon operations • Evaluation of emissions • Partial portfolio shift towards • Decarbonization • Vast majority of and goals to reduce non hydrocarbon products fully integrated investment toward • Beginning to integrate into financial and carbon mitigation Description decarb. into portfolio portfolio decisions and low-carbon decision-making • Strong investment into • Focus shifts externally to and investment low-carbon innovation facilitate societal • Some divestment from high- and R&D decarbonization carbon assets Scope 1,2 and 3 physical Carbon intensity1 60-75 40-60 10-40 < 10 (CO2-e/MJ) Severity of the actions and weight on overall portfolio IOC IOC IOC IOC Former IOC IOC IOC IOC IOC IOC IOC IOC 1. Without offsets or credits Example: Today 2050 under current targets © Oliver Wyman 32
REACHING NEUTRALITY REQUIRES A REDEFINITION OF THE O&G PRODUCT PORTFOLIO OVER COMING YEARS AND DECADES Modeled evolution of product and asset portfolio % of MJ, with resulting physical CI in g CO 2-e/MJ above bars – assumes consistent total energy production MODELED EXAMPLE In line with current In line with 2 degrees Paris pledges and below Starting physical CI 75-95 60-75 40-60 10-40 < 10 (all emission scopes) based on average emissions across the value chain Low-CI fuels1 of a boe, for average Renewable power industry portfolio Natural gas Non-combustible oil product Light oil based combustible product 2 Heavy oil based combustible product2 Low-carbon Carbon Small steps Shifting gears champion Neutrality 1. Includes low-CI biofuels, green or blue hydrogen, electric vehicle charging, etc. || 2. American Petroleum Institute (API) gravity < 35 for Heavy and API gravity > 35 for Light in this example Source: OW Analysis © Oliver Wyman 33
THANK YOU FOR YOUR ATTENTION! 1 The current COVID-triggered crisis has created a unique shock to the industry and caused significant impact on oil and gas companies, currently still recovering 2 We are headed for a “new normal” characterized by lower demand, low prices, a stronger OPEC+ alliance and reinforcement of US shale as natural swing producer 3 Despite sustained challenges, we see market consolidation, decarbonization and energy transition as accelerating changes © Oliver Wyman 34
THANK YOU; POST-WEBINAR LOGISTICS; Q&A Contact us Til Schuermann Til.Schuermann@oliverwyman.com Helen Leis Helen.Leis@oliverwyman.com Doug Elliott Douglas.Elliott@oliverwyman.com Bob Orr Bob.Orr@oliverwyman.com © Oliver Wyman 35
READ OUR LATEST INSIGHTS ABOUT COVID-19 AND ITS GLOBAL IMPACT ONLINE Oliver Wyman and our parent company Marsh & McLennan Visit our dedicated COVID-19 website: (MMC) have been monitoring the latest events and are putting https://www.oliverwyman.com/coronavirus forth our perspectives to support our clients and the industries they serve around the world. Our dedicated COVID-19 digital destination will be updated daily as the situation evolves © Oliver Wyman 36
QUALIFICATIONS, ASSUMPTIONS, AND LIMITING CONDITIONS This report is for the exclusive use of the Oliver Wyman client named herein. This report is not intended for general circulation or publication, nor is it to be reproduced, quoted, or distributed for any purpose without the prior written permission of Oliver Wyman. There are no third-party beneficiaries with respect to this report, and Oliver Wyman does not accept any liability to any third party. Information furnished by others, upon which all or portions of this report are based, is believed to be reliable but has not been independently verified, unless otherwise expressly indicated. Public information and industry and statistical data are from sources we deem to be reliable; however, we make no representation as to the accuracy or completeness of such information. The findings contained in this report may contain predictions based on current data and historical trends. Any such predictions are subject to inherent risks and uncertainties. Oliver Wyman accepts no responsibility for actual results or future events. The opinions expressed in this report are valid only for the purpose stated herein and as of the date of this report. No obligation is assumed to revise this report to reflect changes, events, or conditions, which occur subsequent to the date hereof. All decisions in connection with the implementation or use of advice or recommendations contained in this report are the sole responsibility of the client. This report does not represent investment advice nor does it provide an opinion regarding the fairness of any transaction to any and all parties. In addition, this report does not represent legal, medical, accounting, safety, or other specialized advice. For any such advice, Oliver Wyman recommends seeking and obtaining advice from a qualified professional.
You can also read